1. Home
  2. Disease & Disorders
  3. New York, NY
  4. Heart Valve Collaboratory

Heart Valve Collaboratory

Heart Valve Collaboratory has an America's Best Score of 34 out of 100, based on its 2024 Form 990, below the 60-point bar to be ranked.

  • New York, NY
  • Tax-exempt since 2021
  • EIN: 85-3443532
heartvalvecollaboratory.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
34OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Heart Valve Collaboratory is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G05). Contributions are tax-deductible.

1700 Broadway Fl 9, New York, NY 10019-6231

Among the 85 scored disease & disorders organizations in New York, Heart Valve Collaboratory holds -21.3 months of operating reserves (peer median 11.2 months), runs a typical yearly deficit of 8.7% (peers: surplus of 0.8%), and has grown spending 8.5% a year (peers: grown spending 6.1% a year).

In fiscal year 2024 it reported $241,239 in revenue and $286,540 in expenses, with contributions making up 45.2% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

To create a dynamic, interactive collaborative community of stakeholders under a single umbrella for the purpose of catalyzing clinical research, advancing regulatory science, addressing knowledge gaps and creating meaningful advances in our understanding of valvular heart disease.

Main program · fiscal year 2024

  • Through working groups hvc pursues a variety of projects aimed at deepening the understanding and improving the treatment of valvular heart disease with different work products and end goals such as consensus documents, think tanks, and clinical trial designs. Through these activities hvc creates a dynamic, interactive collaboration community of stakeholders under a single umbrella for the purpose… Read more

    Through working groups hvc pursues a variety of projects aimed at deepening the understanding and improving the treatment of valvular heart disease with different work products and end goals such as consensus documents, think tanks, and clinical trial designs. Through these activities hvc creates a dynamic, interactive collaboration community of stakeholders under a single umbrella for the purpose of catalyzing clinical research, advancing regulatory policy, addressing knowledge gaps and creating meaningful advances in our understanding of valvular heart disease

    $249,974 spent

Where each dollar went · fiscal year 2024

Of every dollar it spent, 87¢ went to programs, 13¢ to management and 0¢ to fundraising.

  • Programs $249,974
  • Management $36,566
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score34 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves-21.3 mo; 5.8 mo in cash0 / 25
Financial balance (median margin)−8.7%5.7 / 20
Transparency2 full 990s, latest TY202415 / 20
Program growth+8.5% / yr11.8 / 15
Track record5 years2 / 10
Debt load396.7% of assets0 / 10
Total34.4 → 34
Spending on programs
Not scored; America's Best needs 65%+
87%Meets

Compared with New York peers

MeasureThis organizationPeer median
Operating reserves-21.3 mo11.2 mo
Typical margin−8.7%+0.8%
Spending growth+8.5% / yr+6.1% / yr
Debt load396.7%7.4%

Peers: the 85 New York disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$241,239Fiscal year 20242022: $239,66720222024: $241,2392024
Expenses$286,540Fiscal year 20242022: $243,34020222024: $286,5402024
Total assets$171,397Fiscal year 20242022: $237,86220222024: $171,3972024
Total liabilities$679,920Fiscal year 20242022: $373,50920222024: $679,9202024
Fiscal year ending December 2024
Revenue$241,239
Expenses$286,540
Net income−$45,301
Net assets−$508,523

Notable sources of revenue

Percent of total revenue
Contributions$109,064
Program services$132,175
Investment income$0
Other (net)$0

Assets / debt

Total assets$171,397
Total liabilities$679,920
Net assets−$508,523

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$239,667
Expenses$243,340
Net income−$3,673
Net assets−$135,647

Notable sources of revenue

Percent of total revenue
Contributions$239,667
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets$237,862
Total liabilities$373,509
Net assets−$135,647

Compensation

Officers and key employees$0
Share of expenses0.0%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?